Brachytherapy Market Size by Technique, Product, Application, End-User, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2032
7.4%
CAGR (2026-2032)
1112.97 USD Mn.
Market Size
300
Report Pages
144
Market Tables
Overview
Brachytherapy market size was US$ 1112.97 Mn in 2025 and is expected to reach US$ 1834.48 Mn by 2032, at a CAGR of 7.4 % during the forecast period.
Brachytherapy Market Definition
Brachytherapy is the type of radiotherapy that is widely used to treat cancers such as prostate, breast, skin, and others. In Brachytherapy radioactive material called source is placed inside the body of cancer patients in order to kill cancer cells and to shrink tumours.
To know about the Research Methodology :- Request Free Sample Report
Brachytherapy market Dynamics
The g4rowing use of Brachytherapy by doctors to treat various cancers such as prostate, skin, breast, stomach, cervix, brain, neck, lung, and many others is a major driving factor behind the growth of the market. Growing technological advancements in Brachytherapy, increasing investment by market players for research and development activities in this field, growing adoption of negligible invasive surgeries, rising number of cancer patients across the globe, and surging demand to treat cancer at the first stage are expected to improve the growth of the market during the forecast period. Brachytherapy provides some major benefits such as effective treatment of cancer, high level of accuracy, and high possibility of permanently curing cancer, which ultimately propels the market growth.
However, the possibility of side effects to the area being treated and the availability of alternative cancer treatment methods are major restraining factors that could hamper the growth of the market.
Brachytherapy Market Segment Analysis
By technique, a high dose rate (HDR) Brachytherapy segment dominated the market in 2025 and is expected to maintain its dominance at CAGR of xx% during the forecast period. HDR Brachytherapy is the type of internal radiotherapy. It is a dominant treatment method of internally delivered radiation therapy that kills various kinds of cancer cells such as prostate, skin, breast, and cervical. HDR Brachytherapy provides some benefits such as highly accurate internally delivered radiation therapy, convenient treatment, generally pain-free treatment, and reduced risk of common long- and short- term side effects, which makes them the most used treatment method for cancer.
By application, the prostate cancer segment dominated the market in 2025 and is projected to witness fast growth at CAGR of xx% during the forecast period. Prostate cancer is that kind of cancer which develops in the prostate gland and one of the most common types of cancer that occurs in the men worldwide. According to research, it is found that, in 2018, 1.3 million new cases of prostate cancer are registered globally and most importantly 6 out of 10 men have a risk of getting diagnosed with prostate cancer in their lifetime. The incidence rate of prostate cancers is highest in North America, and Australia/New Zealand. Age-standardized incidence rates of prostate cancer have increased noticeably. The increasing age-adjusted incidence rate of prostate cancer worldwide is expected to improve the growth of the market during the forecast period. Alternatively, the breast cancer segment is projected to witness fast growth at CAGR of xx% during the forecast period. Increasing incidence of breast cancer among women across the world is impelling the growth of the market.
Brachytherapy Market Regional Analysis
Region-wise, North America dominated the market in 2025 and is expected to maintain its dominance at a CAGR of xx% during the forecast period. The US and Canada are the major contributors behind the growth of the market in the region. The growth is attributed to the increasing use of the Brachytherapy treatment method to cure cancer patients across the region.
An increasing number of prostates, lung, breast, bronchus, and colorectal cancer patients across the US is driving the growth of the market across the region. These types of cancer are accounted for nearly 50% of all cancer cases in the United States. It is estimated that by the end of 2020, there will be approximately 1.8 Mn people will be diagnosed with cancer in the United States. Breast cancer and prostate cancer are the most common cancer types that are occurred in men and women of the US. As per MMR study, approximately 276,480 women and 2,620 men will be diagnosed with breast cancer and 191,930 men will be diagnosed with prostate cancer by 2020.
The objective of the report is to present a comprehensive analysis of the Global Brachytherapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Brachytherapy Market dynamics, structure by analyzing the market segments and projects the Global Brachytherapy Market. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Brachytherapy Market make the report investor’s guide.
Brachytherapy market Scope: Inquiry Before Buying
| global brachytherapy market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 1112.97 USD Mn |
| Forecast Period 2026-2032 CAGR: | 7.4% | Market Size in 2032: | 1834.48 USD Mn |
| Segments Covered: | by Technique | High Dose Rate (HDR) Brachytherapy Low Dose Rate (LDR) Brachytherapy Pulse Dose Rate (PDR) Brachytherapy Image Guided Brachytherapy (IGBT) |
|
| by Product | Brachytherapy After Loader Brachytherapy Applicators Intracavitary Applicators Intraluminal Applicators Interstitial Applicators Intraoperative and Surface Applicators Brachytherapy Software |
||
| by Application | Prostate Cancer Breast Cancer Gynecological Cancer Cervical Cancer Skin Cancer Others (Lung, Head, Neck) |
||
| by End-User | Hospitals Specialty Clinics Others |
||
Global Brachytherapy Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Key Player / Competitors Profile Covered in Global Brachytherapy Market Report in Strategic Perspective:
1. Boston Scientific
2. C4 Imaging
3. CIVCO Radiotherapy
4. Concure Oncology’s
5. Elekta AB
6. Varian Medical Systems
7. Theragenics Corporation
8. iCAD Inc
9. IsoAid
10. C. R. Bard, Inc
11. Sun Nuclear Corporation
12. Mevion Medical Systems, Inc
13. IsoRay Medical, Inc
14. Argon Medical Devices, Inc
15. Cianna Medical
16. Eckert & Ziegler
17. Hitachi, Ltd
18. Panacea Medical Technologies Pvt. Ltd
19. Elketa Mexico
Table of Contents
Global Brachytherapy Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Brachytherapy Market Size, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Brachytherapy Market Analysis and Forecast
6.1. Brachytherapy Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Brachytherapy Market Analysis and Forecast, By Technique
7.1. Introduction and Definition
7.2. Key Findings
7.3. Brachytherapy Market Value Share Analysis, By Technique
7.4. Brachytherapy Market Size (US$ Bn) Forecast, By Technique
7.5. Brachytherapy Market Analysis, By Technique
7.6. Brachytherapy Market Attractiveness Analysis, By Technique
8. Global Brachytherapy Market Analysis and Forecast, By Product
8.1. Introduction and Definition
8.2. Key Findings
8.3. Brachytherapy Market Value Share Analysis, By Product
8.4. Brachytherapy Market Size (US$ Bn) Forecast, By Product
8.5. Brachytherapy Market Analysis, By Product
8.6. Brachytherapy Market Attractiveness Analysis, By Product
9. Global Brachytherapy Market Analysis and Forecast, By Application
9.1. Introduction and Definition
9.2. Key Findings
9.3. Brachytherapy Market Value Share Analysis, By Application
9.4. Brachytherapy Market Size (US$ Bn) Forecast, By Application
9.5. Brachytherapy Market Analysis, By Application
9.6. Brachytherapy Market Attractiveness Analysis, By Application
10. Global Brachytherapy Market Analysis and Forecast, By End User
10.1. Introduction and Definition
10.2. Key Findings
10.3. Brachytherapy Market Value Share Analysis, By End User
10.4. Brachytherapy Market Size (US$ Bn) Forecast, By End User
10.5. Brachytherapy Market Analysis, By End User
10.6. Brachytherapy Market Attractiveness Analysis, By End User
11. Global Brachytherapy Market Analysis, by Region
11.1. Brachytherapy Market Value Share Analysis, by Region
11.2. Brachytherapy Market Size (US$ Bn) Forecast, by Region
11.3. Brachytherapy Market Attractiveness Analysis, by Region
12. North America Brachytherapy Market Analysis
12.1. Key Findings
12.2. North America Brachytherapy Market Overview
12.3. North America Brachytherapy Market Value Share Analysis, By Technique
12.4. North America Brachytherapy Market Forecast, By Technique
12.4.1. High Dose Rate (HDR) Brachytherapy
12.4.2. Low Dose Rate (LDR) Brachytherapy
12.4.3. Pulse Dose Rate (PDR) Brachytherapy
12.4.4. Image Guided Brachytherapy (IGBT)
12.5. North America Brachytherapy Market Value Share Analysis, By Product
12.6. North America Brachytherapy Market Forecast, By Product
12.6.1. Brachytherapy After Loader
12.6.2. Brachytherapy Applicators
12.6.2.1. Intracavitary Applicators
12.6.2.2. Intraluminal Applicators
12.6.2.3. Interstitial Applicators
12.6.2.4. Intraoperative and Surface Applicators
12.6.3. Brachytherapy Software
12.7. North America Brachytherapy Market Value Share Analysis, By Application
12.8. North America Brachytherapy Market Forecast, By Application
12.8.1. Prostate Cancer
12.8.2. Breast Cancer
12.8.3. Gynecological Cancer
12.8.4. Cervical Cancer
12.8.5. Skin Cancer
12.8.6. Others (Lung, Head, Neck)
12.9. North America Brachytherapy Market Value Share Analysis, By End User
12.10. North America Brachytherapy Market Forecast, By End User
12.10.1. Hospitals
12.10.2. Specialty Clinics
12.10.3. Others
12.11. North America Brachytherapy Market Value Share Analysis, by Country
12.12. North America Brachytherapy Market Forecast, by Country
12.12.1. U.S.
12.12.2. Canada
12.13. North America Brachytherapy Market Analysis, by Country
12.14. U.S. Brachytherapy Market Forecast, By Technique
12.14.1. High Dose Rate (HDR) Brachytherapy
12.14.2. Low Dose Rate (LDR) Brachytherapy
12.14.3. Pulse Dose Rate (PDR) Brachytherapy
12.14.4. Image Guided Brachytherapy (IGBT)
12.15. U.S. Brachytherapy Market Forecast, By Product
12.15.1. Brachytherapy After Loader
12.15.2. Brachytherapy Applicators
12.15.2.1. Intracavitary Applicators
12.15.2.2. Intraluminal Applicators
12.15.2.3. Interstitial Applicators
12.15.2.4. Intraoperative and Surface Applicators
12.15.3. Brachytherapy Software
12.16. U.S. Brachytherapy Market Forecast, By Application
12.16.1. Prostate Cancer
12.16.2. Breast Cancer
12.16.3. Gynecological Cancer
12.16.4. Cervical Cancer
12.16.5. Skin Cancer
12.16.6. Others (Lung, Head, Neck)
12.17. U.S. Brachytherapy Market Forecast, By End User
12.17.1. Hospitals
12.17.2. Specialty Clinics
12.17.3. Others
12.18. Canada Brachytherapy Market Forecast, By Technique
12.18.1. High Dose Rate (HDR) Brachytherapy
12.18.2. Low Dose Rate (LDR) Brachytherapy
12.18.3. Pulse Dose Rate (PDR) Brachytherapy
12.18.4. Image Guided Brachytherapy (IGBT)
12.19. Canada Brachytherapy Market Forecast, By Product
12.19.1. Brachytherapy After Loader
12.19.2. Brachytherapy Applicators
12.19.2.1. Intracavitary Applicators
12.19.2.2. Intraluminal Applicators
12.19.2.3. Interstitial Applicators
12.19.2.4. Intraoperative and Surface Applicators
12.19.3. Brachytherapy Software
12.20. Canada Brachytherapy Market Forecast, By Application
12.20.1. Prostate Cancer
12.20.2. Breast Cancer
12.20.3. Gynecological Cancer
12.20.4. Cervical Cancer
12.20.5. Skin Cancer
12.20.6. Others (Lung, Head, Neck)
12.21. Canada Brachytherapy Market Forecast, By End User
12.21.1. Hospitals
12.21.2. Specialty Clinics
12.21.3. Others
12.22. North America Brachytherapy Market Attractiveness Analysis
12.22.1. By Technique
12.22.2. By Product
12.22.3. By Application
12.22.4. By End User
12.23. PEST Analysis
12.24. Key Trends
12.25. Key Developments
13. Europe Brachytherapy Market Analysis
13.1. Key Findings
13.2. Europe Brachytherapy Market Overview
13.3. Europe Brachytherapy Market Value Share Analysis, By Technique
13.4. Europe Brachytherapy Market Forecast, By Technique
13.4.1. High Dose Rate (HDR) Brachytherapy
13.4.2. Low Dose Rate (LDR) Brachytherapy
13.4.3. Pulse Dose Rate (PDR) Brachytherapy
13.4.4. Image Guided Brachytherapy (IGBT)
13.5. Europe Brachytherapy Market Value Share Analysis, By Product
13.6. Europe Brachytherapy Market Forecast, By Product
13.6.1. Brachytherapy After Loader
13.6.2. Brachytherapy Applicators
13.6.2.1. Intracavitary Applicators
13.6.2.2. Intraluminal Applicators
13.6.2.3. Interstitial Applicators
13.6.2.4. Intraoperative and Surface Applicators
13.6.3. Brachytherapy Software
13.7. Europe Brachytherapy Market Value Share Analysis, By Application
13.8. Europe Brachytherapy Market Forecast, By Application
13.8.1. Prostate Cancer
13.8.2. Breast Cancer
13.8.3. Gynecological Cancer
13.8.4. Cervical Cancer
13.8.5. Skin Cancer
13.8.6. Others (Lung, Head, Neck)
13.9. Europe Brachytherapy Market Value Share Analysis, By End User
13.10. Europe Brachytherapy Market Forecast, By End User
13.10.1. Hospitals
13.10.2. Specialty Clinics
13.10.3. Others
13.11. Europe Brachytherapy Market Value Share Analysis, by Country
13.12. Europe Brachytherapy Market Forecast, by Country
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Europe Brachytherapy Market Analysis, by Country
13.14. Germany Brachytherapy Market Forecast, By Technique
13.14.1. High Dose Rate (HDR) Brachytherapy
13.14.2. Low Dose Rate (LDR) Brachytherapy
13.14.3. Pulse Dose Rate (PDR) Brachytherapy
13.14.4. Image Guided Brachytherapy (IGBT)
13.15. Germany Brachytherapy Market Forecast, By Product
13.15.1. Brachytherapy After Loader
13.15.2. Brachytherapy Applicators
13.15.2.1. Intracavitary Applicators
13.15.2.2. Intraluminal Applicators
13.15.2.3. Interstitial Applicators
13.15.2.4. Intraoperative and Surface Applicators
13.15.3. Brachytherapy Software
13.16. Germany Brachytherapy Market Forecast, By Application
13.16.1. Prostate Cancer
13.16.2. Breast Cancer
13.16.3. Gynecological Cancer
13.16.4. Cervical Cancer
13.16.5. Skin Cancer
13.16.6. Others (Lung, Head, Neck)
13.17. Germany Brachytherapy Market Forecast, By End User
13.17.1. Hospitals
13.17.2. Specialty Clinics
13.17.3. Others
13.18. U.K. Brachytherapy Market Forecast, By Technique
13.18.1. High Dose Rate (HDR) Brachytherapy
13.18.2. Low Dose Rate (LDR) Brachytherapy
13.18.3. Pulse Dose Rate (PDR) Brachytherapy
13.18.4. Image Guided Brachytherapy (IGBT)
13.19. U.K. Brachytherapy Market Forecast, By Product
13.19.1. Brachytherapy After Loader
13.19.2. Brachytherapy Applicators
13.19.2.1. Intracavitary Applicators
13.19.2.2. Intraluminal Applicators
13.19.2.3. Interstitial Applicators
13.19.2.4. Intraoperative and Surface Applicators
13.19.3. Brachytherapy Software
13.20. U.K. Brachytherapy Market Forecast, By Application
13.20.1. Prostate Cancer
13.20.2. Breast Cancer
13.20.3. Gynecological Cancer
13.20.4. Cervical Cancer
13.20.5. Skin Cancer
13.20.6. Others (Lung, Head, Neck)
13.21. U.K. Brachytherapy Market Forecast, By End User
13.21.1. Hospitals
13.21.2. Specialty Clinics
13.21.3. Others
13.22. France Brachytherapy Market Forecast, By Technique
13.22.1. High Dose Rate (HDR) Brachytherapy
13.22.2. Low Dose Rate (LDR) Brachytherapy
13.22.3. Pulse Dose Rate (PDR) Brachytherapy
13.22.4. Image Guided Brachytherapy (IGBT)
13.23. France Brachytherapy Market Forecast, By Product
13.23.1. Brachytherapy After Loader
13.23.2. Brachytherapy Applicators
13.23.2.1. Intracavitary Applicators
13.23.2.2. Intraluminal Applicators
13.23.2.3. Interstitial Applicators
13.23.2.4. Intraoperative and Surface Applicators
13.23.3. Brachytherapy Software
13.24. France Brachytherapy Market Forecast, By Application
13.24.1. Prostate Cancer
13.24.2. Breast Cancer
13.24.3. Gynecological Cancer
13.24.4. Cervical Cancer
13.24.5. Skin Cancer
13.24.6. Others (Lung, Head, Neck)
13.25. France Brachytherapy Market Forecast, By End User
13.25.1. Hospitals
13.25.2. Specialty Clinics
13.25.3. Others
13.26. Italy Brachytherapy Market Forecast, By Technique
13.26.1. High Dose Rate (HDR) Brachytherapy
13.26.2. Low Dose Rate (LDR) Brachytherapy
13.26.3. Pulse Dose Rate (PDR) Brachytherapy
13.26.4. Image Guided Brachytherapy (IGBT)
13.27. Italy Brachytherapy Market Forecast, By Product
13.27.1. Brachytherapy After Loader
13.27.2. Brachytherapy Applicators
13.27.2.1. Intracavitary Applicators
13.27.2.2. Intraluminal Applicators
13.27.2.3. Interstitial Applicators
13.27.2.4. Intraoperative and Surface Applicators
13.27.3. Brachytherapy Software
13.28. Italy Brachytherapy Market Forecast, By Application
13.28.1. Prostate Cancer
13.28.2. Breast Cancer
13.28.3. Gynecological Cancer
13.28.4. Cervical Cancer
13.28.5. Skin Cancer
13.28.6. Others (Lung, Head, Neck)
13.29. Italy Brachytherapy Market Forecast, By End User
13.29.1. Hospitals
13.29.2. Specialty Clinics
13.29.3. Others
13.30. Spain Brachytherapy Market Forecast, By Technique
13.30.1. High Dose Rate (HDR) Brachytherapy
13.30.2. Low Dose Rate (LDR) Brachytherapy
13.30.3. Pulse Dose Rate (PDR) Brachytherapy
13.30.4. Image Guided Brachytherapy (IGBT)
13.31. Spain Brachytherapy Market Forecast, By Product
13.31.1. Brachytherapy After Loader
13.31.2. Brachytherapy Applicators
13.31.2.1. Intracavitary Applicators
13.31.2.2. Intraluminal Applicators
13.31.2.3. Interstitial Applicators
13.31.2.4. Intraoperative and Surface Applicators
13.31.3. Brachytherapy Software
13.32. Spain Brachytherapy Market Forecast, By Application
13.32.1. Prostate Cancer
13.32.2. Breast Cancer
13.32.3. Gynecological Cancer
13.32.4. Cervical Cancer
13.32.5. Skin Cancer
13.32.6. Others (Lung, Head, Neck)
13.33. Spain Brachytherapy Market Forecast, By End User
13.33.1. Hospitals
13.33.2. Specialty Clinics
13.33.3. Others
13.34. Rest of Europe Brachytherapy Market Forecast, By Technique
13.34.1. High Dose Rate (HDR) Brachytherapy
13.34.2. Low Dose Rate (LDR) Brachytherapy
13.34.3. Pulse Dose Rate (PDR) Brachytherapy
13.34.4. Image Guided Brachytherapy (IGBT)
13.35. Rest of Europe Brachytherapy Market Forecast, By Product
13.35.1. Brachytherapy After Loader
13.35.2. Brachytherapy Applicators
13.35.2.1. Intracavitary Applicators
13.35.2.2. Intraluminal Applicators
13.35.2.3. Interstitial Applicators
13.35.2.4. Intraoperative and Surface Applicators
13.35.3. Brachytherapy Software
13.36. Rest of Europe Brachytherapy Market Forecast, By Application
13.36.1. Prostate Cancer
13.36.2. Breast Cancer
13.36.3. Gynecological Cancer
13.36.4. Cervical Cancer
13.36.5. Skin Cancer
13.36.6. Others (Lung, Head, Neck)
13.37. Rest Of Europe Brachytherapy Market Forecast, By End User
13.37.1. Hospitals
13.37.2. Specialty Clinics
13.37.3. Others
13.38. Europe Brachytherapy Market Attractiveness Analysis
13.38.1. By Technique
13.38.2. By Product
13.38.3. By Application
13.38.4. By End User
13.39. PEST Analysis
13.40. Key Trends
13.41. Key Developments
14. Asia Pacific Brachytherapy Market Analysis
14.1. Key Findings
14.2. Asia Pacific Brachytherapy Market Overview
14.3. Asia Pacific Brachytherapy Market Value Share Analysis, By Technique
14.4. Asia Pacific Brachytherapy Market Forecast, By Technique
14.4.1. High Dose Rate (HDR) Brachytherapy
14.4.2. Low Dose Rate (LDR) Brachytherapy
14.4.3. Pulse Dose Rate (PDR) Brachytherapy
14.4.4. Image Guided Brachytherapy (IGBT)
14.5. Asia Pacific Brachytherapy Market Value Share Analysis, By Product
14.6. Asia Pacific Brachytherapy Market Forecast, By Product
14.6.1. Brachytherapy After Loader
14.6.2. Brachytherapy Applicators
14.6.2.1. Intracavitary Applicators
14.6.2.2. Intraluminal Applicators
14.6.2.3. Interstitial Applicators
14.6.2.4. Intraoperative and Surface Applicators
14.6.3. Brachytherapy Software
14.7. Asia Pacific Brachytherapy Market Value Share Analysis, By Application
14.8. Asia Pacific Brachytherapy Market Forecast, By Application
14.8.1. Prostate Cancer
14.8.2. Breast Cancer
14.8.3. Gynecological Cancer
14.8.4. Cervical Cancer
14.8.5. Skin Cancer
14.8.6. Others (Lung, Head, Neck)
14.9. Asia Pacific Brachytherapy Market Value Share Analysis, By End User
14.10. Asia Pacific Brachytherapy Market Forecast, By End User
14.10.1. Hospitals
14.10.2. Specialty Clinics
14.10.3. Others
14.11. Asia Pacific Brachytherapy Market Value Share Analysis, by Country
14.12. Asia Pacific Brachytherapy Market Forecast, by Country
14.12.1. China
14.12.2. India
14.12.3. Japan
14.12.4. ASEAN
14.12.5. Rest of Asia Pacific
14.13. Asia Pacific Brachytherapy Market Analysis, by Country
14.14. China Brachytherapy Market Forecast, By Technique
14.14.1. High Dose Rate (HDR) Brachytherapy
14.14.2. Low Dose Rate (LDR) Brachytherapy
14.14.3. Pulse Dose Rate (PDR) Brachytherapy
14.14.4. Image Guided Brachytherapy (IGBT)
14.15. China Brachytherapy Market Forecast, By Product
14.15.1. Brachytherapy After Loader
14.15.2. Brachytherapy Applicators
14.15.2.1. Intracavitary Applicators
14.15.2.2. Intraluminal Applicators
14.15.2.3. Interstitial Applicators
14.15.2.4. Intraoperative and Surface Applicators
14.15.3. Brachytherapy Software
14.16. China Brachytherapy Market Forecast, By Application
14.16.1. Prostate Cancer
14.16.2. Breast Cancer
14.16.3. Gynecological Cancer
14.16.4. Cervical Cancer
14.16.5. Skin Cancer
14.16.6. Others (Lung, Head, Neck)
14.17. China Brachytherapy Market Forecast, By End User
14.17.1. Hospitals
14.17.2. Specialty Clinics
14.17.3. Others
14.18. India Brachytherapy Market Forecast, By Technique
14.18.1. High Dose Rate (HDR) Brachytherapy
14.18.2. Low Dose Rate (LDR) Brachytherapy
14.18.3. Pulse Dose Rate (PDR) Brachytherapy
14.18.4. Image Guided Brachytherapy (IGBT)
14.19. India Brachytherapy Market Forecast, By Product
14.19.1. Brachytherapy After Loader
14.19.2. Brachytherapy Applicators
14.19.2.1. Intracavitary Applicators
14.19.2.2. Intraluminal Applicators
14.19.2.3. Interstitial Applicators
14.19.2.4. Intraoperative and Surface Applicators
14.19.3. Brachytherapy Software
14.20. India Brachytherapy Market Forecast, By Application
14.20.1. Prostate Cancer
14.20.2. Breast Cancer
14.20.3. Gynecological Cancer
14.20.4. Cervical Cancer
14.20.5. Skin Cancer
14.20.6. Others (Lung, Head, Neck)
14.21. India Brachytherapy Market Forecast, By End User
14.21.1. Hospitals
14.21.2. Specialty Clinics
14.21.3. Others
14.22. Japan Brachytherapy Market Forecast, By Technique
14.22.1. High Dose Rate (HDR) Brachytherapy
14.22.2. Low Dose Rate (LDR) Brachytherapy
14.22.3. Pulse Dose Rate (PDR) Brachytherapy
14.22.4. Image Guided Brachytherapy (IGBT)
14.23. Japan Brachytherapy Market Forecast, By Product
14.23.1. Brachytherapy After Loader
14.23.2. Brachytherapy Applicators
14.23.2.1. Intracavitary Applicators
14.23.2.2. Intraluminal Applicators
14.23.2.3. Interstitial Applicators
14.23.2.4. Intraoperative and Surface Applicators
14.23.3. Brachytherapy Software
14.24. Japan Brachytherapy Market Forecast, By Application
14.24.1. Prostate Cancer
14.24.2. Breast Cancer
14.24.3. Gynecological Cancer
14.24.4. Cervical Cancer
14.24.5. Skin Cancer
14.24.6. Others (Lung, Head, Neck)
14.25. Japan Brachytherapy Market Forecast, By End User
14.25.1. Hospitals
14.25.2. Specialty Clinics
14.25.3. Others
14.26. ASEAN Brachytherapy Market Forecast, By Technique
14.26.1. High Dose Rate (HDR) Brachytherapy
14.26.2. Low Dose Rate (LDR) Brachytherapy
14.26.3. Pulse Dose Rate (PDR) Brachytherapy
14.26.4. Image Guided Brachytherapy (IGBT)
14.27. ASEAN Brachytherapy Market Forecast, By Product
14.27.1. Brachytherapy After Loader
14.27.2. Brachytherapy Applicators
14.27.2.1. Intracavitary Applicators
14.27.2.2. Intraluminal Applicators
14.27.2.3. Interstitial Applicators
14.27.2.4. Intraoperative and Surface Applicators
14.27.3. Brachytherapy Software
14.28. ASEAN Brachytherapy Market Forecast, By Application
14.28.1. Prostate Cancer
14.28.2. Breast Cancer
14.28.3. Gynecological Cancer
14.28.4. Cervical Cancer
14.28.5. Skin Cancer
14.28.6. Others (Lung, Head, Neck)
14.29. ASEAN Brachytherapy Market Forecast, By End User
14.29.1. Hospitals
14.29.2. Specialty Clinics
14.29.3. Others
14.30. Rest of Asia Pacific Brachytherapy Market Forecast, By Technique
14.30.1. High Dose Rate (HDR) Brachytherapy
14.30.2. Low Dose Rate (LDR) Brachytherapy
14.30.3. Pulse Dose Rate (PDR) Brachytherapy
14.30.4. Image Guided Brachytherapy (IGBT)
14.31. Rest of Asia Pacific Brachytherapy Market Forecast, By Product
14.31.1. Brachytherapy After Loader
14.31.2. Brachytherapy Applicators
14.31.2.1. Intracavitary Applicators
14.31.2.2. Intraluminal Applicators
14.31.2.3. Interstitial Applicators
14.31.2.4. Intraoperative and Surface Applicators
14.31.3. Brachytherapy Software
14.32. Rest of Asia Pacific Brachytherapy Market Forecast, By Application
14.32.1. Prostate Cancer
14.32.2. Breast Cancer
14.32.3. Gynecological Cancer
14.32.4. Cervical Cancer
14.32.5. Skin Cancer
14.32.6. Others (Lung, Head, Neck)
14.33. Rest of Asia Pacific Brachytherapy Market Forecast, By End User
14.33.1. Hospitals
14.33.2. Specialty Clinics
14.33.3. Others
14.34. Asia Pacific Brachytherapy Market Attractiveness Analysis
14.34.1. By Technique
14.34.2. By Product
14.34.3. By Application
14.34.4. By End User
14.35. PEST Analysis
14.36. Key Trends
14.37. Key Developments
15. Middle East & Africa Brachytherapy Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Brachytherapy Market Overview
15.3. Middle East & Africa Brachytherapy Market Value Share Analysis, By Technique
15.4. Middle East & Africa Brachytherapy Market Forecast, By Technique
15.4.1. High Dose Rate (HDR) Brachytherapy
15.4.2. Low Dose Rate (LDR) Brachytherapy
15.4.3. Pulse Dose Rate (PDR) Brachytherapy
15.4.4. Image Guided Brachytherapy (IGBT)
15.5. Middle East & Africa Brachytherapy Market Value Share Analysis, By Product
15.6. Middle East & Africa Brachytherapy Market Forecast, By Product
15.6.1. Brachytherapy After Loader
15.6.2. Brachytherapy Applicators
15.6.2.1. Intracavitary Applicators
15.6.2.2. Intraluminal Applicators
15.6.2.3. Interstitial Applicators
15.6.2.4. Intraoperative and Surface Applicators
15.6.3. Brachytherapy Software
15.7. Middle East & Africa Brachytherapy Market Value Share Analysis, By Application
15.8. Middle East & Africa Brachytherapy Market Forecast, By Application
15.8.1. Prostate Cancer
15.8.2. Breast Cancer
15.8.3. Gynecological Cancer
15.8.4. Cervical Cancer
15.8.5. Skin Cancer
15.8.6. Others (Lung, Head, Neck)
15.9. Middle East & Africa Brachytherapy Market Value Share Analysis, By End User
15.10. Middle East & Africa Brachytherapy Market Forecast, By End User
15.10.1. Hospitals
15.10.2. Specialty Clinics
15.10.3. Others
15.11. Middle East & Africa Brachytherapy Market Value Share Analysis, by Country
15.12. Middle East & Africa Brachytherapy Market Forecast, by Country
15.12.1. GCC
15.12.2. South Africa
15.12.3. Rest of Middle East & Africa
15.13. Middle East & Africa Brachytherapy Market Analysis, by Country
15.14. GCC Brachytherapy Market Forecast, By Technique
15.14.1. High Dose Rate (HDR) Brachytherapy
15.14.2. Low Dose Rate (LDR) Brachytherapy
15.14.3. Pulse Dose Rate (PDR) Brachytherapy
15.14.4. Image Guided Brachytherapy (IGBT)
15.15. GCC Brachytherapy Market Forecast, By Product
15.15.1. Brachytherapy After Loader
15.15.2. Brachytherapy Applicators
15.15.2.1. Intracavitary Applicators
15.15.2.2. Intraluminal Applicators
15.15.2.3. Interstitial Applicators
15.15.2.4. Intraoperative and Surface Applicators
15.15.3. Brachytherapy Software
15.16. GCC Brachytherapy Market Forecast, By Application
15.16.1. Prostate Cancer
15.16.2. Breast Cancer
15.16.3. Gynecological Cancer
15.16.4. Cervical Cancer
15.16.5. Skin Cancer
15.16.6. Others (Lung, Head, Neck)
15.17. GCC Brachytherapy Market Forecast, By End User
15.17.1. Hospitals
15.17.2. Specialty Clinics
15.17.3. Others
15.18. South Africa Brachytherapy Market Forecast, By Technique
15.18.1. High Dose Rate (HDR) Brachytherapy
15.18.2. Low Dose Rate (LDR) Brachytherapy
15.18.3. Pulse Dose Rate (PDR) Brachytherapy
15.18.4. Image Guided Brachytherapy (IGBT)
15.19. South Africa Brachytherapy Market Forecast, By Product
15.19.1. Brachytherapy After Loader
15.19.2. Brachytherapy Applicators
15.19.2.1. Intracavitary Applicators
15.19.2.2. Intraluminal Applicators
15.19.2.3. Interstitial Applicators
15.19.2.4. Intraoperative and Surface Applicators
15.19.3. Brachytherapy Software
15.20. South Africa Brachytherapy Market Forecast, By Application
15.20.1. Prostate Cancer
15.20.2. Breast Cancer
15.20.3. Gynecological Cancer
15.20.4. Cervical Cancer
15.20.5. Skin Cancer
15.20.6. Others (Lung, Head, Neck)
15.21. South Africa Brachytherapy Market Forecast, By End User
15.21.1. Hospitals
15.21.2. Specialty Clinics
15.21.3. Others
15.22. Rest of Middle East & Africa Brachytherapy Market Forecast, By Technique
15.22.1. High Dose Rate (HDR) Brachytherapy
15.22.2. Low Dose Rate (LDR) Brachytherapy
15.22.3. Pulse Dose Rate (PDR) Brachytherapy
15.22.4. Image Guided Brachytherapy (IGBT)
15.23. Rest of Middle East & Africa Brachytherapy Market Forecast, By Product
15.23.1. Brachytherapy After Loader
15.23.2. Brachytherapy Applicators
15.23.2.1. Intracavitary Applicators
15.23.2.2. Intraluminal Applicators
15.23.2.3. Interstitial Applicators
15.23.2.4. Intraoperative and Surface Applicators
15.23.3. Brachytherapy Software
15.24. Rest of Middle East & Africa Brachytherapy Market Forecast, By Application
15.24.1. Prostate Cancer
15.24.2. Breast Cancer
15.24.3. Gynecological Cancer
15.24.4. Cervical Cancer
15.24.5. Skin Cancer
15.24.6. Others (Lung, Head, Neck)
15.25. Rest of Middle East & Africa Brachytherapy Market Forecast, By End User
15.25.1. Hospitals
15.25.2. Specialty Clinics
15.25.3. Others
15.26. Middle East & Africa Brachytherapy Market Attractiveness Analysis
15.26.1. By Technique
15.26.2. By Product
15.26.3. By Application
15.26.4. By End User
15.27. PEST Analysis
15.28. Key Trends
15.29. Key Developments
16. South America Brachytherapy Market Analysis
16.1. Key Findings
16.2. South America Brachytherapy Market Overview
16.3. South America Brachytherapy Market Value Share Analysis, By Technique
16.4. South America Brachytherapy Market Forecast, By Technique
16.4.1. High Dose Rate (HDR) Brachytherapy
16.4.2. Low Dose Rate (LDR) Brachytherapy
16.4.3. Pulse Dose Rate (PDR) Brachytherapy
16.4.4. Image Guided Brachytherapy (IGBT)
16.5. South America Brachytherapy Market Value Share Analysis, By Product
16.6. South America Brachytherapy Market Forecast, By Product
16.6.1. Brachytherapy After Loader
16.6.2. Brachytherapy Applicators
16.6.2.1. Intracavitary Applicators
16.6.2.2. Intraluminal Applicators
16.6.2.3. Interstitial Applicators
16.6.2.4. Intraoperative and Surface Applicators
16.6.3. Brachytherapy Software
16.7. South America Brachytherapy Market Value Share Analysis, By Application
16.8. South America Brachytherapy Market Forecast, By Application
16.8.1. Prostate Cancer
16.8.2. Breast Cancer
16.8.3. Gynecological Cancer
16.8.4. Cervical Cancer
16.8.5. Skin Cancer
16.8.6. Others (Lung, Head, Neck)
16.9. South America Brachytherapy Market Value Share Analysis, By End User
16.10. South America Brachytherapy Market Forecast, By End User
16.10.1. Hospitals
16.10.2. Specialty Clinics
16.10.3. Others
16.11. South America Brachytherapy Market Value Share Analysis, by Country
16.12. South America Brachytherapy Market Forecast, by Country
16.12.1. Brazil
16.12.2. Mexico
16.12.3. Rest of South America
16.13. South America Brachytherapy Market Analysis, by Country
16.14. Brazil Brachytherapy Market Forecast, By Technique
16.14.1. High Dose Rate (HDR) Brachytherapy
16.14.2. Low Dose Rate (LDR) Brachytherapy
16.14.3. Pulse Dose Rate (PDR) Brachytherapy
16.14.4. Image Guided Brachytherapy (IGBT)
16.15. Brazil Brachytherapy Market Forecast, By Product
16.15.1. Brachytherapy After Loader
16.15.2. Brachytherapy Applicators
16.15.2.1. Intracavitary Applicators
16.15.2.2. Intraluminal Applicators
16.15.2.3. Interstitial Applicators
16.15.2.4. Intraoperative and Surface Applicators
16.15.3. Brachytherapy Software
16.16. Brazil Brachytherapy Market Forecast, By Application
16.16.1. Prostate Cancer
16.16.2. Breast Cancer
16.16.3. Gynecological Cancer
16.16.4. Cervical Cancer
16.16.5. Skin Cancer
16.16.6. Others (Lung, Head, Neck)
16.17. Brazil Brachytherapy Market Forecast, By End User
16.17.1. Hospitals
16.17.2. Specialty Clinics
16.17.3. Others
16.18. Mexico Brachytherapy Market Forecast, By Technique
16.18.1. High Dose Rate (HDR) Brachytherapy
16.18.2. Low Dose Rate (LDR) Brachytherapy
16.18.3. Pulse Dose Rate (PDR) Brachytherapy
16.18.4. Image Guided Brachytherapy (IGBT)
16.19. Mexico Brachytherapy Market Forecast, By Product
16.19.1. Brachytherapy After Loader
16.19.2. Brachytherapy Applicators
16.19.2.1. Intracavitary Applicators
16.19.2.2. Intraluminal Applicators
16.19.2.3. Interstitial Applicators
16.19.2.4. Intraoperative and Surface Applicators
16.19.3. Brachytherapy Software
16.20. Mexico Brachytherapy Market Forecast, By Application
16.20.1. Prostate Cancer
16.20.2. Breast Cancer
16.20.3. Gynecological Cancer
16.20.4. Cervical Cancer
16.20.5. Skin Cancer
16.20.6. Others (Lung, Head, Neck)
16.21. Mexico Brachytherapy Market Forecast, By End User
16.21.1. Hospitals
16.21.2. Specialty Clinics
16.21.3. Others
16.22. Rest of South America Brachytherapy Market Forecast, By Technique
16.22.1. High Dose Rate (HDR) Brachytherapy
16.22.2. Low Dose Rate (LDR) Brachytherapy
16.22.3. Pulse Dose Rate (PDR) Brachytherapy
16.22.4. Image Guided Brachytherapy (IGBT)
16.23. Rest of South America Brachytherapy Market Forecast, By Product
16.23.1. Brachytherapy After Loader
16.23.2. Brachytherapy Applicators
16.23.2.1. Intracavitary Applicators
16.23.2.2. Intraluminal Applicators
16.23.2.3. Interstitial Applicators
16.23.2.4. Intraoperative and Surface Applicators
16.23.3. Brachytherapy Software
16.24. Rest of South America Brachytherapy Market Forecast, By Application
16.24.1. Prostate Cancer
16.24.2. Breast Cancer
16.24.3. Gynecological Cancer
16.24.4. Cervical Cancer
16.24.5. Skin Cancer
16.24.6. Others (Lung, Head, Neck)
16.25. Rest of South America Brachytherapy Market Forecast, By End User
16.25.1. Hospitals
16.25.2. Specialty Clinics
16.25.3. Others
16.26. South America Brachytherapy Market Attractiveness Analysis
16.26.1. By Technique
16.26.2. By Product
16.26.3. By Application
16.26.4. By End User
16.27. PEST Analysis
16.28. Key Trends
16.29. Key Developments
17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
17.2.2. New Product Launches and Product Enhancements
17.2.3. Market Consolidation
17.2.3.1. M&A by Regions, Investment and Applications
17.2.3.2. M&A Key Players, Forward Integration and Backward Integration
17.3. Company Profiles: Key Players
17.3.1. Boston Scientific
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategy
17.3.1.5. Recent Developments
17.3.1.6. Development Footprint
17.3.2. C4 Imaging
17.3.3. CIVCO Radiotherapy
17.3.4. Concure Oncology’s
17.3.5. Elekta AB
17.3.6. Varian Medical Systems
17.3.7. Theragenics Corporation
17.3.8. iCAD Inc
17.3.9. IsoAid
17.3.10. C. R. Bard, Inc
17.3.11. Sun Nuclear Corporation
17.3.12. Mevion Medical Systems, Inc
17.3.13. IsoRay Medical, Inc
17.3.14. Argon Medical Devices, Inc
17.3.15. Cianna Medical
17.3.16. Eckert & Ziegler
17.3.17. Hitachi, Ltd
17.3.18. Panacea Medical Technologies Pvt. Ltd
17.3.19. Elketa Mexico
18. Primary Key Insights